Fluorescently labeled nanocarriers (PTPR‐FITC, GFP‐FITC, or PGFP‐FITC) were intravenously injected into 4T1 tumor‐bearing BALB/c mice to evaluate the circulation dynamics and biodistribution. This evidence concerns the gene PTPRR and neoplasm.